Myrbetriq 8 MG/ML 24 HR Extended Release Suspension

RxCUI: 2541237
RxNorm name: Myrbetriq 8 MG/ML 24 HR Extended Release Suspension
Display name: Myrbetriq 8 MG/ML 24 HR Extended Release Suspension
Full name: Myrbetriq 8 MG/ML 24 HR Extended Release Suspension
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Myrbetriq	MIRABEGRON	Astellas Pharma US, Inc.	ba9e9e15-e666-4c56-9271-2e24739cfa2d	2024-08-01	Warnings, Adverse reactions	Exact identifier rxcui: 2541237

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
ba9e9e15-e666-4c56-9271-2e24739cfa2d	Myrbetriq 8 MG/ML 24 HR Extended Release Suspension	SY	17	These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 2012	20240801
ba9e9e15-e666-4c56-9271-2e24739cfa2d	24 HR Myrbetriq 8 MG/ML Extended Release Suspension	SY	17	These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 2012	20240801
ba9e9e15-e666-4c56-9271-2e24739cfa2d	24 HR mirabegron 8 MG/ML Extended Release Suspension [Myrbetriq]	SBD	17	These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 2012	20240801
ba9e9e15-e666-4c56-9271-2e24739cfa2d	Myrbetriq Granules 8 MG/mL 24HR Extended Release Suspension	PSN	17	These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 2012	20240801